Description

FYLOW is a respiratory medication containing 400 mg of Doxofylline, a xanthine derivative that acts as a bronchodilator. Unlike older medications in its class, Doxofylline is designed to have a better safety profile with fewer cardiac side effects. It is primarily used for the long-term treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). FYLOW serves as an essential maintenance therapy to prevent bronchospasm and shortness of breath, helping patients maintain clearer airways and better daily lung function. Each pack contains 10 tablets intended for regular, preventative use rather than immediate rescue relief.